Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. [electronic resource]
Producer: 20150318Description: 573-81 p. digitalISSN:- 1573-2568
- Adult
- Antiviral Agents -- adverse effects
- Biomarkers -- blood
- Carcinoma, Hepatocellular -- diagnosis
- Chi-Square Distribution
- Disease Progression
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Incidence
- Interferon alpha-2
- Interferon-alpha -- adverse effects
- Kaplan-Meier Estimate
- Liver Cirrhosis -- diagnosis
- Liver Neoplasms -- diagnosis
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Polyethylene Glycols -- adverse effects
- Protective Factors
- RNA, Viral -- blood
- Recombinant Proteins -- adverse effects
- Republic of Korea -- epidemiology
- Retrospective Studies
- Ribavirin -- adverse effects
- Risk Factors
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.